This document summarizes information about the drug Olanzapine (brand name Zyprexa), including its classification as an antipsychotic drug, indications for treatment of schizophrenia and bipolar disorder, contraindications, usual and actual doses, potential side effects, and nursing responsibilities when administering the drug. Key details provided include antagonizing dopamine and serotonin type 2 receptors in the central nervous system, dosing starting at 5-10 mg/day and increasing up to 20 mg/day maximum, common side effects like somnolence and weight gain, and nursing responsibilities like monitoring for side effects, drug interactions, and signs of dehydration in elderly patients.
This document summarizes information about the drug Olanzapine (brand name Zyprexa), including its classification as an antipsychotic drug, indications for treatment of schizophrenia and bipolar disorder, contraindications, usual and actual doses, potential side effects, and nursing responsibilities when administering the drug. Key details provided include antagonizing dopamine and serotonin type 2 receptors in the central nervous system, dosing starting at 5-10 mg/day and increasing up to 20 mg/day maximum, common side effects like somnolence and weight gain, and nursing responsibilities like monitoring for side effects, drug interactions, and signs of dehydration in elderly patients.
This document summarizes information about the drug Olanzapine (brand name Zyprexa), including its classification as an antipsychotic drug, indications for treatment of schizophrenia and bipolar disorder, contraindications, usual and actual doses, potential side effects, and nursing responsibilities when administering the drug. Key details provided include antagonizing dopamine and serotonin type 2 receptors in the central nervous system, dosing starting at 5-10 mg/day and increasing up to 20 mg/day maximum, common side effects like somnolence and weight gain, and nursing responsibilities like monitoring for side effects, drug interactions, and signs of dehydration in elderly patients.
This document summarizes information about the drug Olanzapine (brand name Zyprexa), including its classification as an antipsychotic drug, indications for treatment of schizophrenia and bipolar disorder, contraindications, usual and actual doses, potential side effects, and nursing responsibilities when administering the drug. Key details provided include antagonizing dopamine and serotonin type 2 receptors in the central nervous system, dosing starting at 5-10 mg/day and increasing up to 20 mg/day maximum, common side effects like somnolence and weight gain, and nursing responsibilities like monitoring for side effects, drug interactions, and signs of dehydration in elderly patients.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1/ 3
DRUG STUDY
Generic Brand Classification Mode of Indication Contraindication Usual Dose Actual Side Effect Nursing Name Name Action Dose Responsibility Antipsychotic Antagonizes Treatment -Contraindicated Schizophrenia: 10mg/ CNS: Somnolence, - Before O Z Drug dopamine of schizophrenia with allergy to ola Initially, 5– ODT, dizziness, nervousness, administration: L Y and serotonin nzapine, myelopr 10 mg PO 10DT headache, akathisia, per Observe for 10R’s A P type 2 in the Treatment of acute oliferative disorde daily, increase now sonality properly. N R CNS. Also mixed or manic rs, severe to 10 mg PO disorders, tardive dyski Z E has episodes associated CNS depression, daily within nesia, neuroleptic malig -Instruct to take this A X anticholinergi with bipolar 1 disorder comatose several days; nant syndrome drug exactly as P A c, and maintenance of states, and may be prescribed; do not I antihistamine bipolar 1 disorder as lactation. increased by 5 CV: Orthostatic hypote change dose without N , and anti- monotherapy, or mg/day at 1- nsion, peripheral consulting your health E alpha1- combined with lithium -Use cautiously in wk intervals to edema, tachycardia care provider adrenergic or valproate elderly or achieve effects. debilitated desired effect. GI: Constipation, abdo -Monitor for the many Treatment of agitation patients, or with Do not exceed minal pain possible drug associated CV or 20 mg/day. interactions before with schizophrenia an cerebrovascular Respiratory: Cough beginning therapy. d bipolar 1 mania disease, dehydrati and pharyngitis. (injection) on, seizure disord -Monitor elderly ers, Alzheimer’s Other: Fever, weight patients disease, prostate gain, joint pain, for dehydration and enlargement, development institute remedial narrow-angle of diabetes mellitus measures promptly; glaucoma, history sedation and of decreased sensation of paralytic ileus or thirst related to CNS breast cancer, effects of drug can pregnancy; lead to dehydration. phenylketonuria (if using orally disintegrating -Encourage patient to tablets, contain void before taking the phenylalanine). drug to help decrease anticholinerg ic effects of urinary retention.
-Monitor for elevations of temperature and differentiate between infection and neuroleptic malignant syndrome.
-Monitor for orthostatic hypotensio n and provide appropriate safety measures as needed.
-Monitor patient regularly for signs and symptoms of diabetes mellitus.
"Acute Coronary Syndrome Non ST Elevation Myocardial Infarction, Hypertensive Cardiovascular Disease, Diabetes Mellitus Type 2, and Community Acquired Pneumonia" Intro
